Acuta Capital Partners’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.12M | Sell |
74,087
-13,054
| -15% | -$549K | 4.35% | 9 |
|
|
2025
Q1 | $3.3M | Buy |
87,141
+19,641
| +29% | +$744K | 3.83% | 10 |
|
|
2024
Q4 | $5.19M | Buy |
67,500
+10,000
| +17% | +$770K | 5.23% | 7 |
|
|
2024
Q3 | $3.31M | Sell |
57,500
-106,931
| -65% | -$6.15M | 2.68% | 15 |
|
|
2024
Q2 | $6.8M | Buy |
164,431
+2,129
| +1% | +$88.1K | 5.73% | 5 |
|
|
2024
Q1 | $9.9M | Sell |
162,302
-137,334
| -46% | -$8.38M | 6.43% | 2 |
|
|
2023
Q4 | $6.68M | Buy |
299,636
+636
| +0.2% | +$14.2K | 3.76% | 8 |
|
|
2023
Q3 | $7.67M | Buy |
299,000
+15,667
| +6% | +$402K | 5.14% | 4 |
|
|
2023
Q2 | $4.89M | Buy |
+283,333
| New | +$4.89M | 3.31% | 12 |
|
|
2021
Q2 | – | Sell |
-10,282
| Closed | -$5.05M | – | 46 |
|
|
2021
Q1 | $5.05M | Buy |
10,282
+5,239
| +104% | +$2.57M | 1.82% | 25 |
|
|
2020
Q4 | $4.16M | Buy |
+5,043
| New | +$4.16M | 1.13% | 31 |
|